A comprehensive view of Kraig Biocraft Laboratories Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Bioeconomy Market Intelligence Service.
Kraig Biocraft Laboratories announces that spring production trials for the new BAM-1 hybrid have begun and are on track to meet company's expectations, timeline; BAM-1 is Kraig Labs' newest, most robust recombinant spider silk production silkworm hybrid
Published:
April 15, 2024
by Kraig Biocraft Laboratories Inc.
|
KRAIG BIOCRAFT LABORATORIES, INC - 10-K - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Published:
April 01, 2024
by SEC Edgar Filings
|
KRAIG BIOCRAFT LABORATORIES, INC - (8-K) - Disclosing Unregistered Sales of Equity Securities
Published:
April 01, 2024
by SEC Edgar Filings
|
Kraig Biocraft Labs CEO 'encouraged' by RPI's method of creating spider silk protein from waste plastics; Kraig's recombinant spider silk production model is different, as RPI method uses new strain of bacteria to depolymerize PE into recombinant proteins
Published:
March 28, 2024
by Kraig Biocraft Laboratories Inc.
|
Kraig Biocraft Labs welcomes leading sericulture expert from India for its launch of Spring production trials; he is tasked with reviewing the company's production operations and that of its third party contract manufacturers
Published:
March 19, 2024
by Globe Newswire
|
Ask us about our Bioeconomy market view